Synapticure

We deliver personalized medicine for neurodegenerative patients
Location
Year Founded
2019
Company Size
11 - 50 People
Hiring
Funding Raised
Not Specified
About Synapticure
Synapticure aims to provide neurodegenerative patients, starting with ALS and PD, access to the best care while fueling the advancement of personalized treatments.
We do so by providing end-to-end clinical care using our telemedicine platform to guide patients through their entire care journey. We are devoted to helping patients, from guidance on care and insurance to providing the full spectrum of investigational and clinical testing to improve outcomes.
Synapticure was built by leading patient and caregiver advocates alongside leading ALS and PD clinicians, biotech executives and telemedicine executives to bring the neurodegenerative disease care and treatment experience into the 21st century, and is backed by the leading Venture funds and Angel investors in the remote health and life sciences space.
We do so by providing end-to-end clinical care using our telemedicine platform to guide patients through their entire care journey. We are devoted to helping patients, from guidance on care and insurance to providing the full spectrum of investigational and clinical testing to improve outcomes.
Synapticure was built by leading patient and caregiver advocates alongside leading ALS and PD clinicians, biotech executives and telemedicine executives to bring the neurodegenerative disease care and treatment experience into the 21st century, and is backed by the leading Venture funds and Angel investors in the remote health and life sciences space.
Profile ID: #325872
Latest Jobs
Founders & Leadership
Financials Beta
Business Model: Not Specified
Revenues: Not Specified
Expenses: Not Specified
Debt: Request
Operating Status: Active
Funding Raised: $0
Investment Rounds: 0 Rounds
Funding Stage: Not Specified
Last Funding Date: Not Specified